| Name | Relationship | Address | Signature | Signature date | CIK |
|---|---|---|---|---|---|
| Baker-Nel Deena | SVP & Chief HR Officer | 8080 NORTON PARKWAY, MENTOR | /s/ Vikas Arora attorney-in-fact for Deena Baker-Nel | 03 Mar 2026 | 0001823548 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | AVY | Common Stock | Options Exercise | $84,145 | +432 | +8.1% | $194.78 | 5,779 | 01 Mar 2026 | Direct | |
| transaction | AVY | Common Stock | Tax liability | $29,217 | -150 | -2.6% | $194.78 | 5,629 | 01 Mar 2026 | Direct | |
| transaction | AVY | Common Stock | Options Exercise | $70,316 | +361 | +6.4% | $194.78 | 5,990 | 01 Mar 2026 | Direct | |
| transaction | AVY | Common Stock | Tax liability | $21,036 | -108 | -1.8% | $194.78 | 5,882 | 01 Mar 2026 | Direct | |
| transaction | AVY | Common Stock | Options Exercise | $61,356 | +315 | +5.4% | $194.78 | 6,197 | 01 Mar 2026 | Direct | |
| transaction | AVY | Common Stock | Tax liability | $18,309 | -94 | -1.5% | $194.78 | 6,103 | 01 Mar 2026 | Direct | |
| transaction | AVY | Common Stock | Options Exercise | $125,828 | +646 | +11% | $194.78 | 6,749 | 01 Mar 2026 | Direct | |
| transaction | AVY | Common Stock | Tax liability | $37,593 | -193 | -2.9% | $194.78 | 6,556 | 01 Mar 2026 | Direct | |
| transaction | AVY | Common Stock | Options Exercise | $157,967 | +811 | +12% | $194.78 | 7,367 | 01 Mar 2026 | Direct | |
| transaction | AVY | Common Stock | Tax liability | $47,137 | -242 | -3.3% | $194.78 | 7,125 | 01 Mar 2026 | Direct | |
| holding | AVY | Common Stock (Savings Plan) | 1,722 | 01 Mar 2026 | Savings Plan |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | AVY | 2026 RSU Award | Award | $0 | +2,119 | $0.000000 | 2,119 | 01 Mar 2026 | Common Stock | 2,119 | $0.000000 | Direct | F1 | |
| transaction | AVY | 2026 PU Award | Award | $0 | +3,063 | $0.000000 | 3,063 | 01 Mar 2026 | Common Stock | 3,063 | $0.000000 | Direct | F2 | |
| transaction | AVY | 2022 MSU Award | Options Exercise | $0 | -432 | -100% | $0.000000 | 0 | 01 Mar 2026 | Common Stock | 432 | $0.000000 | Direct | F3 |
| transaction | AVY | 2023 MSU Award | Options Exercise | $0 | -361 | -50% | $0.000000 | 357 | 01 Mar 2026 | Common Stock | 361 | $0.000000 | Direct | F4 |
| transaction | AVY | 2024 MSU Award | Options Exercise | $0 | -315 | -32% | $0.000000 | 661 | 01 Mar 2026 | Common Stock | 315 | $0.000000 | Direct | F5 |
| transaction | AVY | 2025 MSU Award | Options Exercise | $0 | -646 | -24% | $0.000000 | 2,021 | 01 Mar 2026 | Common Stock | 646 | $0.000000 | Direct | F6 |
| transaction | AVY | 2023 PU Award | Options Exercise | $0 | -811 | -100% | $0.000000 | 0 | 01 Mar 2026 | Common Stock | 811 | $0.000000 | Direct | F7 |
| Id | Content |
|---|---|
| F1 | Restricted stock units (RSUs) vest 25% on each of the first, second, third and fourth anniversaries of the grant date. Each RSU represents a contingent right to receive one share of common stock. |
| F2 | Performance units (PUs) vest, at the end of fiscal year 2028, provided certain performance objectives are met as determined by the Compensation Committee in February 2029. Each PU represents a contingent right to receive one share of common stock. |
| F3 | Shares reflect the vesting of the fourth tranche of MSUs granted in February 2022 at 92% of target based on our absolute total stockholder return in excess of 10% during the 2022-2025 performance period, plus dividend equivalents accrued during the period. |
| F4 | Shares reflect the vesting of the third tranche of MSUs granted in March 2023 at 96% of target based on our absolute total stockholder return during the 2023-2025 performance period, plus dividend equivalents accrued during the period. |
| F5 | Shares reflect the vesting of the second tranche of MSUs granted in March 2024 at 92% of target based on our absolute total stockholder return during the 2024-2025 performance period, plus dividend equivalents accrued during the period. |
| F6 | Shares reflect the vesting of the first tranche of MSUs granted in March 2025 at 94% of target based on our absolute total stockholder return during the 2025 performance period, plus dividend equivalents accrued during the period. |
| F7 | Shares reflect the vesting of PUs granted in March 2023 at 56% of target, based 50% on our cumulative economic value added of 0% of target and 50% on our relative total stockholder return of 112% of target. |